The stock is in a powerful, sustained uptrend, evidenced by a staggering 424.6% one-year price change, and is currently trading at approximately 95% of its 52-week high of $151.00, indicating extreme momentum and potential overextension. Recent momentum has accelerated sharply, with a 86.3% gain over the past month and a 107.6% gain over three months, far outpacing the broader market (SPY up 6.3% and 10.3% over the same periods), signaling intense speculative buying. Key technical levels are the 52-week high at $151.00 serving as immediate resistance and the 52-week low at $25.24 as distant support; a breakout above resistance would confirm the bullish trend, while the stock's beta of 2.31 indicates it is over 130% more volatile than the market, necessitating outsized risk tolerance for investors.

Revenue growth is accelerating dramatically, with Q4 2025 revenue of $179.7 million representing a 35.7% year-over-year increase, and sequential quarterly revenue has climbed from $122.6 million in Q1 to $179.7 million in Q4, indicating robust demand. The company remains unprofitable with a Q4 net income of -$52.9 million, but gross margin improved to 38.0% from 28.7% in Q1 2025, showing progress on operational efficiency, though the operating margin was -28.4%. Financially, the balance sheet shows a strong current ratio of 4.08 and low debt-to-equity of 0.15, but free cash flow remains deeply negative at -$321.8 million TTM, indicating the company is still burning significant cash to fund its aggressive growth and capital expenditures.